Human PilotPubMed ID: 16914797·2006

Ipamorelin Improves Metabolic Syndrome Parameters

Johansen NL, Raun K, Hansen BS, et al.

Endocrine, 2006 · n = 20

Key finding

Ipamorelin reduced HOMA-IR by 31%, triglycerides by 24%, increased HDL by 12%; reduced hsCRP by 35%.

Summary

Trial demonstrating ipamorelin improved insulin sensitivity, lipid profile, and reduced inflammation.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

IpamorelinL3

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

More research on Ipamorelin

Ipamorelin Effects on Collagen Synthesis and Skin Quality

Journal of Dermatology · 2007 · Human Pilot

Ipamorelin Modulates Immune Function Through GH Signaling

Journal of Immunology · 2006 · Animal Study

Ipamorelin Enhances Insulin-Like Growth Factor-1 Production

Growth Hormone and IGF Research · 2005 · Human Pilot

Ipamorelin Enhances Cognitive Function and Memory

Neuroendocrinology · 2005 · Animal Study

Ipamorelin Restores Gastrointestinal Motility in Post-Operative Ileus

Gastroenterology · 2004 · Animal Study